StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$1.99−0.02 (-1.00%)

Close on Nov 18, 2026Market cap $14.66MP/E –Yield –

GeoVax Labs price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

GeoVax Labs's price to sales ratio was 54.1× on Jul 31, 2026, against 64.6× a year earlier. Over the last 3 years it ranged from 0.0× to 458.9×, with a median of 71.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202654.1×+16.2
2025Dec 31, 202537.9×−421.1
2020Feb 28, 2020458.9×+399.0
2019Sep 30, 201959.9×−16.3
2018Dec 31, 201876.2×–

More GeoVax Labs figures

See a number that looks wrong?